Higher 24-hour ambulatory blood pressure measurement and non-dipping status associated with cerebrovascular white matter disease [0.03%]
24小时动态血压水平升高和非勺型血压与脑小血管病的关系
Micheal J Bloch,Jan Basile
Micheal J Bloch
Jackson T Wright,Kenneth A Jamerson,Keith C Ferdinand
Jackson T Wright
A panel was convened to discuss the topic of the management of hypertension in the African American patient. Jackson T. Wright, MD, PhD, Professor of Medicine, Case Western Reserve University, Cleveland, OH, moderated the panel. Kenneth A. ...
Michael J Bloch,Jan N Basile
Michael J Bloch
Debbie L Cohen,Raymond R Townsend
Debbie L Cohen
Pantelis A Sarafidis,Angeliki I Kanaki,Anastasios N Lasaridis
Pantelis A Sarafidis
In addition to the lipid-lowering effects of statins, several basic and clinical studies in recent years have examined the effects of these agents on other cardiovascular parameters. Some of these studies investigated the general impact of ...
The pathophysiologic role of the brain renin-angiotensin system in stroke protection: clinical implications [0.03%]
脑肾素血管紧张素系统在卒中保护中的病理生理作用及临床意义
Steven G Chrysant
Steven G Chrysant
The brain possesses the same renin-angiotensin system (RAS) as the systemic circulation. Recent experimental studies have shown that the brain RAS plays an important role in stroke and neuronal protection through its effector peptide angiot...
Kamakshi Lakshminarayan,David C Anderson,Catherine Borbas et al.
Kamakshi Lakshminarayan et al.
Data from the Project for Improvement of Stroke Care Management in Minnesota were used to characterize provider practice in the management of hypertension in hospitalized acute ischemic stroke patients in relation to guidelines from the Ame...
Coronary heart disease events preventable by control of blood pressure and lipids in US adults with hypertension [0.03%]
美国高血压成人可通过控制血压和血脂而避免冠心病事件
Victor A Lopez,Stanley S Franklin,Simon Tang et al.
Victor A Lopez et al.
Hypertension (HTN) and dyslipidemia are major risk factors for coronary heart disease (CHD). In 676 (projected to 26.1 million) US persons from the National Health and Nutrition Examination Survey (NHANES) 2001-2002 with HTN, the authors es...
Effects of candesartan and lisinopril on the fibrinolytic system in hypertensive patients [0.03%]
坎地沙坦和 Lisinopril 对高血压患者纤溶系统的影响
Michael M Hirschl,Andreas Bur,Christian Woisetschlaeger et al.
Michael M Hirschl et al.
The effects of the angiotensin II receptor blocker candesartan and the angiotensin-converting enzyme inhibitor lisinopril on the fibrinolytic system were investigated in a double-blinded, prospective, randomized study. Seventy-seven hyperte...
Randomized Controlled Trial
Journal of clinical hypertension (Greenwich, Conn.). 2007 Jun;9(6):430-5. DOI:10.1111/j.1524-6175.2007.06506.x 2007